نتائج البحث - "A Gelibter"

1

دورية أكاديمية

CD137⁺ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.

المؤلفون: Gelibter, Alain¹ (AUTHOR), Asquino, Angela² (AUTHOR), Strigari, Lidia³ (AUTHOR), Zizzari, Ilaria Grazia² (AUTHOR), Tuosto, Lucrezia² (AUTHOR), Scirocchi, Fabio² (AUTHOR), Pace, Angelica² (AUTHOR), Siringo, Marco¹ (AUTHOR), Tramontano, Elisa¹ (AUTHOR), Bianchini, Serena⁴ (AUTHOR), Bellati, Filippo⁵ (AUTHOR), Botticelli, Andrea¹ (AUTHOR), Paoli, Donatella⁴ (AUTHOR), Santini, Daniele¹ (AUTHOR), Nuti, Marianna² (AUTHOR), Rughetti, Aurelia² (AUTHOR), Napoletano, Chiara² (AUTHOR) chiara.napoletano@uniroma1.it

المصدر: Journal of Translational Medicine. 4/3/2024, Vol. 22 Issue 1, p1-16. 16p.

مصطلحات موضوعية: *REGULATORY T cells, *IMMUNOTHERAPY, *PROGNOSIS, *T cells, *NON-small-cell lung carcinoma, *IMMUNE checkpoint inhibitors

النص الكامل

2

دورية أكاديمية

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

المؤلفون: Russo A., Russano M., Franchina T., Migliorino M. R., Aprile G., Mansueto G., Berruti A., Falcone A., Aieta M., Gelibter A., Barni S., Maio M., Martelli O., Pantano F., Iacono D., Calvetti L., Quadrini S., Roca E., Vasile E., Imperatori M., Occhipinti M., Galvano A., Petrelli F., Calabro L., Pasquini G., Intagliata S., Ricciardi G. R. R., Tonini G., Santini D., Adamo V.

المساهمون: Russo A., Russano M., Franchina T., Migliorino M.R., Aprile G., Mansueto G., Berruti A., Falcone A., Aieta M., Gelibter A., Barni S., Maio M., Martelli O., Pantano F., Iacono D., Calvetti L., Quadrini S., Roca E., Vasile E., Imperatori M., Occhipinti M., Galvano A., Petrelli F., Calabro L., Pasquini G., Intagliata S., Ricciardi G.R.R., Tonini G., Santini D., Adamo V.

مصطلحات موضوعية: LDH, Nivolumab, NLR, NSCLC, PD-1, PD-L1, PLR, Prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32002809; info:eu-repo/semantics/altIdentifier/wos/WOS:000510269600001; volume:37; issue:3; firstpage:1145; lastpage:1155; numberofpages:11; journal:ADVANCES IN THERAPY; http://hdl.handle.net/10447/407357Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078863228

الإتاحة: https://doi.org/10.1007/s12325-020-01229-wTest
http://hdl.handle.net/10447/407357Test

View record in BASE

3

دورية أكاديمية

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features

المؤلفون: Antonio Passaro, Silvia Novello, Diana Giannarelli, Emilio Bria, Domenico Galetta, Alain Gelibter, Maria Lucia Reale, Simona Carnio, Emanuele Vita, Alessio Stefani, Pamela Pizzutilo, Valeria Stati, Ilaria Attili, Filippo de Marinis

المصدر: Cancers, Vol 13, Iss 2935, p 2935 (2021)

مصطلحات موضوعية: immunotherapy, pleural metastasis, corticosteroid, prognosis, detrimental effect, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

العلاقة: https://www.mdpi.com/2072-6694/13/12/2935Test; https://doaj.org/toc/2072-6694Test; https://doaj.org/article/d7edc8e5947d4a0090e6cf1ce39bc01fTest

الإتاحة: https://doi.org/10.3390/cancers13122935Test
https://doaj.org/article/d7edc8e5947d4a0090e6cf1ce39bc01fTest

View record in BASE

النص الكامل

4

دورية أكاديمية

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

المؤلفون: Landi L., D'Inca F., Gelibter A., Chiari R., Grossi F., Delmonte A., Passaro A., Signorelli D., Gelsomino F., Galetta D., Giannarelli D., Soto Parra H., Minuti G., Tiseo M., Migliorino M. R., Cognetti F., Toschi L., Bidoli P., Piantedosi F., Calabro' L., Cappuzzo F.

المساهمون: Landi, L, D'Inca, F, Gelibter, A, Chiari, R, Grossi, F, Delmonte, A, Passaro, A, Signorelli, D, Gelsomino, F, Galetta, D, Giannarelli, D, Soto Parra, H, Minuti, G, Tiseo, M, Migliorino, M, Cognetti, F, Toschi, L, Bidoli, P, Piantedosi, F, Calabro', L, Cappuzzo, F

مصطلحات موضوعية: Bone metastase, Immunotherapy, Nivolumab, Non-small-cell lung cancer, PD-L1, Bone metastases, Adult, Aged, 80 and over, Antineoplastic Agents, Immunological, Biomarkers, Tumor, Bone Neoplasms, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Cohort Studies, Female, Humans, Lung Neoplasms, Male, Middle Aged, Prognosis, Treatment Outcome, Molecular Targeted Therapy

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31752994; info:eu-repo/semantics/altIdentifier/wos/WOS:000501612400007; volume:7; issue:1; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; http://hdl.handle.net/10281/281350Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85075518457

الإتاحة: https://doi.org/10.1186/s40425-019-0793-8Test
http://hdl.handle.net/10281/281350Test

View record in BASE

5

دورية أكاديمية

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

المؤلفون: Matteo Santoni, Daniel Y. Heng, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Camillo Porta, Marc R. Matrana, Giacomo Cartenì, Simon J. Crabb, Ugo De Giorgi, Umberto Basso, Cristina Masini, Fabio Calabrò, Maria Giuseppa Vitale, Daniele Santini, Francesco Massari, Luca Galli, Giuseppe Fornarini, Riccardo Ricotta, Sebastiano Buti, Paolo Zucali, Orazio Caffo, Franco Morelli, Francesco Carrozza, Angelo Martignetti, Alain Gelibter, Roberto Iacovelli, Alessandra Mosca, Francesco Atzori, Nuno Vau, Lorena Incorvaia, Cinzia Ortega, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Vittorio Paolucci, Jeffrey Graham, Erin Pierce, Sarah Scagliarini, Pierangela Sepe, Elena Verzoni, Sara Merler, Mimma Rizzo, Giulia Sorgentoni, Alessandro Conti, Francesco Piva, Alessia Cimadamore, Rodolfo Montironi, Nicola Battelli

المصدر: Cancers; Volume 12; Issue 1; Pages: 84

مصطلحات موضوعية: cabozantinib, nivolumab, prognosis, real-world data, renal cell carcinoma, targeted therapy

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/cancers12010084Test

الإتاحة: https://doi.org/10.3390/cancers12010084Test

View record in BASE

6

دورية أكاديمية

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factor

المؤلفون: Santoni, Matteo, Heng, Daniel Y., Bracarda, Sergio, Procopio, Giuseppe, Milella, Michele, Porta, Camillo, Matrana, Marc R., Cartenì, Giacomo, Crabb, Simon J., De Giorgi, Ugo, Basso, Umberto, Masini, Cristina, Calabrò, Fabio, Vitale, Maria Giuseppa, Santini, Daniele, Massari, Francesco, Galli, Luca, Fornarini, Giuseppe, Ricotta, Riccardo, Buti, Sebastiano, Zucali, Paolo, Caffo, Orazio, Morelli, Franco, Carrozza, Francesco, Martignetti, Angelo, Gelibter, Alain, Iacovelli, Roberto, Mosca, Alessandra, Atzori, Francesco, Vau, Nuno, Incorvaia, Lorena, Ortega, Cinzia, Scarpelli, Marina, Lopez-Beltran, Antonio, Cheng, Liang, Paolucci, Vittorio, Graham, Jeffrey, Pierce, Erin, Scagliarini, Sarah, Sepe, Pierangela, Verzoni, Elena, Merler, Sara, Rizzo, Mimma, Sorgentoni, Giulia, Conti, Alessandro, Piva, Francesco, Cimadamore, Alessia, Montironi, Rodolfo, Battelli, Nicola

المساهمون: Pathology and Laboratory Medicine, School of Medicine

المصدر: PMC

مصطلحات موضوعية: Cabozantinib, Nivolumab, Prognosis, Real-world data, Renal cell carcinoma, Targeted therapy

وصف الملف: application/pdf

العلاقة: Cancers; Santoni M, Heng DY, Bracarda S, et al. Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers (Basel). 2019;12(1):84. Published 2019 Dec 30. doi:10.3390/cancers12010084; https://hdl.handle.net/1805/28578Test

الإتاحة: https://doi.org/10.3390/cancers12010084Test
https://hdl.handle.net/1805/28578Test

View record in BASE